Human Papillomavirus (Surepath) EQA/PT Scheme

To assess the proficiency of laboratories in the detection of different high risk Human Papillomavirus types within a SurePath™ matrix.

Total Number of Challenges: 1
Number of Panel Members: 12
Distribution / Testing Period: Q3
Sample NA Target Source Clinical material and/or cell lines containing HPV
Matrix Panel Format Transport Medium (SurePath)
Panel Member Target Range Covering clinical range
Panel Member Sample Volume Lyophilised
Panel Sample Pre-treatment Requirement Reconstitution of lyophilised material.
Panel Analysis Type Qualitative
Panel Testing Evaluated by various molecular methodologies
Storage / Shipment Conditions 2-8°C / Lyophilised Ambient
Accreditation / Regulatory Status Accredited to ISO 17043
SKU: QAV184204_1 Categories: , , Tags: ,

$1,149.49